142.93BMarket Cap
19.05P/E TTM
Key Figures
24.945Open
25.365High
25.35MVolume
19.05P/E TTM
8.84P/E Dynamic
1.720Dividend TTM
0.44%Turnover Ratio
24.820Prev. Close
24.855Low
407.60MTurnover
17.80P/E Static
1.59P/B
6.86%Div Yield TTM
3.62%ROA
28.74552wk High
1.02Volume Ratio
8.03BNet Profit
5.70BShares
1.3167EPS TTM
0.30Beta
8.29%ROE
23.06052wk Low
2.05%Amplitude
68.24%Gross Margin
142.93BMarket Cap
-3.36Reward/Risk
1.35%Risk Rate
Currency: USD Updated: 2026-07-15 Key Insights
Pfizer Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 28.61.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Pfizer Inc Highlights
StrengthsRisks
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Regeneron Pharmaceuticals Inc
REGN
32
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Pfizer Inc Info
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Ticker SymbolPFE
CompanyPfizer Inc
CEOBourla (Albert)
Websitehttps://www.pfizer.com/
Shareholders
FAQs
What is the current price of Pfizer Inc (PFE)?
The current price of Pfizer Inc (PFE) is 24.80.
What is the symbol of Pfizer Inc?
The ticker symbol of Pfizer Inc is PFE.
What is the 52-week high of Pfizer Inc?
The 52-week high of Pfizer Inc is 28.75.
What is the 52-week low of Pfizer Inc?
The 52-week low of Pfizer Inc is 23.06.
What is the market capitalization of Pfizer Inc?
The market capitalization of Pfizer Inc is 141.46B.
Is Pfizer Inc (PFE) currently rated as Buy, Hold, or Sell?
According to analysts, Pfizer Inc (PFE) has an overall rating of signal_hold, with a price target of 28.61.
What is the Earnings Per Share (EPS TTM) of Pfizer Inc (PFE)?
The Earnings Per Share (EPS TTM) of Pfizer Inc (PFE) is 1.37.
